|
|
Volumn 7, Issue 7, 1997, Pages 695-715
|
|
Recent developments in inflammatory bowel disease therapy
|
|
Author keywords
Adhesion molecule inhibition; Antibiotics; Arachidonic acid inhibitors; Crohn's disease; Cytokine inhibitors; Elastase inhibitors; Growth factors; Immunosuppressives; Inflammaory bowel disease; Nitric oxide inhibitors; Nuclear factor B inhibitors; Protease inhibitors; Steroids; Superoxide dismutase mimics; Tachykinin antagonists; Tobacco products; Ulcerative colitis
|
|
Indexed keywords
AZATHIOPRINE;
BRADYKININ ANTAGONIST;
CELL ADHESION MOLECULE;
CORTICOSTEROID;
CYCLOSPORIN;
ELASTASE INHIBITOR;
ENDOTHELIN RECEPTOR ANTAGONIST;
ENZYME INHIBITOR;
GROWTH FACTOR;
IMMUNOMODULATING AGENT;
LEUKOTRIENE B4;
LIPOXYGENASE INHIBITOR;
MESALAZINE;
METHOTREXATE;
NITRIC OXIDE;
PHOSPHOLIPASE A2 INHIBITOR;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PROTEINASE INHIBITOR;
SUPEROXIDE DISMUTASE;
TACHYKININ RECEPTOR ANTAGONIST;
CELL ADHESION;
CROHN DISEASE;
DRUG DEVELOPMENT;
DRUG MARKETING;
ENTERITIS;
HUMAN;
NONHUMAN;
PATENT;
REVIEW;
SMOKING;
ULCERATIVE COLITIS;
|
|
EID: 0030809496
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.7.7.695 Document Type: Review |
|
Times cited : (5)
|
|
References (64)
|
